Drugs / MDMA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05770375 | Sep 2024 → Mar 2027 expected | schizophrenia | Anya Bershad, MD, PhD | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MDMA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05770375 ↗ |